KPIs & Operating Metrics(New)
Breakdown Of AssetsCapital CommitmentsCollaboration Revenue By CategoryCollaboration Revenue By Category AnnualContractual ObligationsDeferred RevenueEmployee StatisticsGross ProfitIncome (Loss) Before Income TaxNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProduct Revenue By CategoryProduct Revenue By Category AnnualProperty And Equipment, Net BreakdownPurchase CommitmentsRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

BeOne Medicines (ONC) Gross Profit (2017 - 2026)

BeOne Medicines (ONC) reported Gross Profit of $1.3 billion for Q1 2026, up 41.37% year-over-year from $952.3 million in Q1 2025, and down 0.7% on a QoQ basis from $1.4 billion in Q4 2025.

BeOne Medicines (ONC) has 10 years of Gross Profit data on file, last reported at $1.3 billion in Q1 2026.

  • Quarterly Gross Profit rose 41.37% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 billion (up 43.11% YoY) and the FY2025 annual result came in at $4.7 billion, up 45.34% from the prior year.
  • Gross Profit retreated to $1.3 billion in Q1 2026 per ONC's latest filing, from $1.4 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $1.4 billion in Q4 2025 and bottomed at $241.4 million in Q1 2022.
  • The 5-year median for Gross Profit is $685.0 million (2023), against an average of $732.1 million.
  • Peak annual rise in Gross Profit reached 137.76% in 2022, while the deepest fall reached 57.89% in 2022.
  • Tracing ONC's Gross Profit over 5 years: stood at $306.6 million in 2022, then jumped by 72.41% to $528.6 million in 2023, then surged by 82.99% to $967.3 million in 2024, then soared by 40.16% to $1.4 billion in 2025, then fell by 0.7% to $1.3 billion in 2026.
  • Per Business Quant, the three latest ONC Gross Profit figures stand at $1.3 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.2 billion (Q3 2025).